Bulletin Updates

Strong results, beat estimates: J.B. Chemicals & Pharmaceuticals – 14 Aug 2023

Aug 14, 2023

The company’s Q1FY24 results were strong, with revenue growth of 14% YoY, EBITDA growth of 34% YoY, and PAT growth of 35.5% YoY

The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »